Sustained complement C1s inhibition with sutimlimab in patients with cold agglutinin disease results in continued efficacy during part B of the randomized placebo-controlled phase 3 CADENZA study (NCT03347422)

被引：0

作者：

Roeth, A. ^{[1
]}

Berentsen, S. ^{[2
]}

Barcellini, W. ^{[3
]}

D'Sa, S. ^{[4
]}

Jilma, B. ^{[5
]}

Michel, M. ^{[6
]}

Weitz, I. C. ^{[7
]}

Yamaguchi, M. ^{[8
]}

Nishimura, J., I ^{[9
]}

Vos, J. M. ^{[10
]}

Cid, J. ^{[11
]}

Storek, M. ^{[12
]}

Wong, N. ^{[12
]}

Yoo, R.

Wang, J. ^{[13
]}

Vagge, D. S. ^{[14
]}

Wardecki, M. ^{[15
]}

Shafer, F. ^{[13
]}

Lee, M. ^{[13
]}

Broome, C. M. ^{[16
]}

机构：

[1] Univ Duisburg, Univ Hosp Essen, West German Canc Ctr, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[2] Haugesund Hosp, Dept Res & Innovat, Haugesund, Norway

[3] Fdn IRCCS Ca Granda Osped Maggiore Policli, Milan, Italy

[4] Univ Coll London Hosp NHS Fdn Trust, UCLH Ctr Waldenstroms Macroglobulinemia & Related, London, England

[5] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria

[6] UPEC, Henri Mondor Univ Hosp, AP HP, Paris, France

[7] USC, Keck Sch Med, Los Angeles, CA USA

[8] Ishikawa Prefectural Cent Hosp, Kanazawa, Japan

[9] Osaka Univ, Grad Sch Med, Osaka, Japan

[10] Amsterdam UMC, Locat AMC, Amsterdam, Netherlands

[11] IDIBAPS, Hosp Clin, Dept Hemotherapy & Hemostasis, ICMHO, Barcelona, Spain

[12] Sanofi, Cambridge, MA USA

[13] Sanofi, Bridgewater, MA USA

[14] IQVIA, Bangalore, India

[15] Sanofi, Warsaw, Poland

[16] MedStar Georgetown Univ Hosp, Div Hematol, Washington, DC USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V851

引用

页码：120 / 120

页数：1

共 50 条

[31] Iscalimab (CFZ533) in Patients with Sjogren's Disease: Week 24 Efficacy and Safety Results of a Randomized, Placebo-controlled, Phase 2b Dose-ranging Study
Fisher, Benjamin A.
Mariette, Xavier
Papas, Athena S.
Grader-Beck, Thomas
Bootsma, Hendrika
Ng, Wan-Fai
Van Daele, Paul
Finzel, Stephanie
Elgueta, Sergio
Hermann, Josef
McCoy, Sara
Bookman, Arthur
Sopala, Monika
Luo, Wen-Lin
Scheurer, Cornelia
Hueber, Wolfgang
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3242 - 3244
[32] Safety and Efficacy of Ianalumab in Patients With Sjögren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study
Doerner, Thomas
Bowman, Simon J.
Fox, Robert
Mariette, Xavier
Papas, Athena
Grader-Beck, Thomas
Fisher, Benjamin A.
Barcelos, Filipe
De Vita, Salvatore
Schulze-Koops, Hendrik
Moots, Robert J.
Junge, Guido
Woznicki, Janice
Sopala, Monika
Avrameas, Alexandre
Luo, Wen-Lin
Hueber, Wolfgang
ARTHRITIS & RHEUMATOLOGY, 2025,
[33] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
Hattori, N.
Takeda, A.
Takeda, S.
Nishimura, A.
Kitagawa, T.
Mochizuki, H.
Nagai, M.
Takahashi, R.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
[34] EFFICACY AND SAFETY OF PEGBELFERMIN IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND STAGE 3 FIBROSIS: RESULTS FROM THE PHASE 2b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED FALCON 1 STUDY
Loomba, Rohit
Sanyal, Arun J.
Nakajima, Atsushi
Neuschwander-Tetri, Brent A.
Goodman, Zachary
Harrison, Stephen A.
Lawitz, Eric J.
Gunn, Nadege
Imajo, Kento
Ravendhran, Natarajan
Akahane, Takemi
Boone, Bradly
Yamaguchi, Masayuki
Chatterjee, Arkendu
Tirucherai, Giridhar S.
Shevell, Diane E.
Du, Shuyan
Charles, Edgar D.
Abdelmalek, Manal F.
HEPATOLOGY, 2021, 74 (06) : 1385A - 1386A
[35] Efficacy and Safety of Brodalumab In Patients With Moderate To Severe Plaque Psoriasis: Results of AMAGINE-1, a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study
Papp, K.
Reich, K.
Blauvelt, A.
Baran, W.
Bolduc, C.
Toth, D.
Gottlieb, A. B.
Thaci, D.
Li, J.
Nirula, A.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
[36] Efficacy and safety of brodalumab in patients with moderate to severe plaque psoriasis: Results of AMAGINE-1, a phase 3, randomized, double-Blind, placebo-controlled study
Papp, Kim
Reich, Kristian
Leonardi, Craig
Paul, Carle
Blauvelt, Andrew
Baran, Wojciech
Bolduc, Chantal
Toth, Darryl
Langley, Richard G.
Cather, Jennifer
Gottlieb, Alice
Thaci, Diamant
Milmont, Cassandra E.
Lim, Joanne
Klekotka, Paul
Kricorian, Greg
Nirula, Ajay
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S8 - S8
[37] Efficacy and safety of apremilast in patients with moderate to severe plaque psoriasis of the scalp: Results of a phase 3b, multicenter, randomized, placebo-controlled, double-blind study
Van Voorhees, Abby S.
Gold, Linda Stein
Lebwohl, Mark
Strober, Bruce
Lynde, Charles
Tyring, Stephen
Cauthen, Ashley
Sofen, Howard
Zhang, Zuoshun
Paris, Maria
Wang, Yao
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 96 - 103
[38] Randomized, Placebo-Controlled, Phase 1b study of the anti-Beta-amyloid antibody Aducanumab (BHB037) in patients with prodromal or Mild Alzheimer's Disease: interim results
Viglietta, V.
Williams, L.
Chen, T.
O'Gorman, J.
Chiao, P.
Hock, C.
Nitsch, R. M.
Sandrock, A.
JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 : S12 - S13
[39] Long-term results of ENGAGE: a phase 3, randomized, double blind, placebo-controlled, multi center study investigating the efficacy and safety of eliglustat in adults with type 1 Gaucher disease
Mistry, Pramod K.
Lukina, Elena
Ben Turkia, Hadhami
Shankar, Suma
Feldman, Hagit Baris
Ghosn, Marwan
Mehta, Atul
Packman, Seymour
Lau, Heather
Petakov, Milan
Assouline, Sarit
Balwani, Manisha
Danda, Sumita
Hadjiev, Evgueniy
Ortega, Andres
Wu, Yaoshi
Gaemers, Sebastiaan J. M.
Peterschmitt, M. Judith
MOLECULAR GENETICS AND METABOLISM, 2017, 120 (1-2) : S97 - S98
[40] A phase 3, randomized, double-blind, placebo-controlled, multi-center study to investigate the efficacy and safety of eliglustat in patients with Gaucher disease type 1 (ENGAGE): Results after 9 months of treatment
Mistry, Pramod
Lukina, Elena
Ben Dridi, Marie-Francoise
Amato, Dominick
Baris, Hagit
Dasouki, Majed
Ghosn, Marwan
Mehta, Atul
Packman, Seymour
Pastores, Gregory
Petakov, Milan
Peterschmitt, M. Judith
MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S66 - S67

← 1 2 3 4 5 →